Drugs and a Methodological Compendium From bench to bedside /
This book provides a meticulous view on methodological drug discovery and development insights from bench to bedside. The current book threads almost each step encompassing drug the discovery and development of a molecule. The chapters focus on computational modus operandi, pharmacological optimizat...
Zapisane w:
| Korporacja: | |
|---|---|
| Kolejni autorzy: | , |
| Format: | Elektroniczne E-book |
| Język: | angielski |
| Wydane: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2023.
|
| Wydanie: | 1st ed. 2023. |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1007/978-981-19-7952-1 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Spis treści:
- Chapter 1.Computational and informatics methodologies in Drug Discovery, with focus on Natural Products
- Chapter 2.Structural biology an essential tool for Drug discovery and Development
- Chapter 3.Bioactivity guided fractionation and identification of bioactive molecules: A basic method in drug discovery
- Chapter 4.In–vitro methodologies for the safety assessment of drugs
- Chapter 5.In-vivo models for evaluation of Drug efficacy: Demand and Challenges
- Chapter 6.Preclinical In vivo Drug Development Studies: Limitations, Model Organisms and Techniques
- Chapter 7.Peptide Based Therapeutics and Drug Delivery Systems
- Chapter 8.Basics of Clinical Drug Development: Clinical Trial and Drug Development
- Chapter 9.Trailblazing contemporary frameworks for drug repurposing: A saga on drugs’ expedition to disinter the veiled destiny
- Chapter 10.Small molecules as promising tool for targeted cancer therapies: an overview of 21st century
- Chapter 11.Nanoparticles for Targeted DrugDelivery Systems with Cancer Therapy in Perspective
- Chapter 12.Biomimetic approach for the controlled drug delivery through 3D bioactive scaffolds: A novel strategy for tissue engineering applications
- Chapter 13.Perspectives on anti-tuberculosis drug discovery
- Chapter 14.Cofactor-Receptor interactions based pharmacophore design for development of novel inhibitors: A case study against Tuberculosis
- Chapter 15.Insilico identification of potential antivirals against SARS-CoV2 main protease and RBD of spike protein – A Drug Repurposing Approach
- Chapter16.Anti-malarial drug discovery and development: from bench to bedside.